Satisfaction study of split doses botulinum toxin with double frequency

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-520915-14-00

Acronym

14031972

Enrollment

Registered

2025-01-29

Start date

2023-01-12

Completion date

Unknown

Last updated

2025-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wrinkles, fine lines

Brief summary

Difference between the intervention and control group in change from baseline eVAS Satisfaction Scale - Overall Satisfaction Score at Visit 6 (follow-up).

Detailed description

Adverse events.

Interventions

DRUGBocouture 100 eenheden poeder voor oplossing voor injectie

DRUGPlacebo to NT201

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
Difference between the intervention and control group in change from baseline eVAS Satisfaction Scale - Overall Satisfaction Score at Visit 6 (follow-up).	—

Secondary

Measure	Time frame
Adverse events.	—

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026